Advanced age and its related comorbidity may affect both the patterns and g
oals of diabetes treatment. We examined the relationships of demographic va
riables and comorbidity with drug treatment for diabetes in the elderly. We
studied both the 81,700 residents of New Jersey, aged 65-99 years, who wer
e hospitalized between July 1, 1989 and June 30, 1991 and had prescription
drug coverage either through Medicaid or the Pharmacy Assistance for the Ag
ed and Disabled program, and a sample of 80,000 nonhospitalized elderly ben
eficiaries in these programs. Plates of utilization of insulin or oral hypo
glycemic drugs in the 120 days before admission were substantially lower in
those aged greater than or equal to 85 or in nursing homes. Among patients
with previously treated and diagnosed diabetes, the likelihood of treatmen
t after discharge declined with older age (odds ratio [OR] for treatment in
those aged greater than or equal to 85 relative to 65-74 years: 0.57; 95%
confidence interval [CI]: 0.45-0.72), nursing hume residence (OR: 0.30; CI:
0.22-0.41), and higher levels of comorbidity (OR for modified Charlson ind
ex greater than or equal to 5 relative to 0: 0.43; CI: 0.27-0.67). In patie
nts who had a discharge diagnosis of diabetes but no Frier treatment, those
in nursing homes and those with greater comorbidity also had lower rates o
f diabetes treatment after discharge. Although the prevalence of diabetes i
ncreases with age and the risks of many consequences of diabetes remain hig
h, the rate of drug treatment for diabetes declines with older age and grea
ter comorbidity, perhaps because of concern about side effects or reduced t
reatment benefits due to competing risks of death. Absence of data from ran
domized clinical trials of diabetes treatment in the elderly appears to hav
e resulted in considerable physician ambivalence on the benefits and risks
of glycemic control in older diabetics. J CLIN EPIDEMIOL 52;8:781-790, 1999
. (C) 1999 Elsevier Science Inc.